Cite
HARVARD Citation
Terada-Hirashima, J. et al. (2023). Immunogenicity and safety of single booster dose of KD-414 inactivated COVID-19 vaccine in adults: An open-label, single-center, non-randomized, controlled study in Japan. Human vaccines & immunotherapeutics. 19 (1), p. . [Online].